Table 2:

Incremental cost-effectiveness ratios, defined as the incremental cost per selected clinical outcome among culture positive cases

	Tanzania	Zambia	Zimbabwe	South Africa	All sites*
Diagnosed by index test	$4254	Point-of-care Xpert†	$1675	$1373	$4186
Starting treatment	$1554	$2699	$1685	$984	$1464
Starting treatment on same day as diagnosis	$1107	$785	$399	$46	$561
Completing treatment	$521	$465	$4309	$8485	$1211
Improved morbidity	$508	$2024	$1710	$3101	$1918

Costs are in $US, 2014.

^*Weighted average of costs and outcomes across all sites, weighted by the number of patients screened and number of clinical outcomes observed at each site.

^†Indicates that point-of-care Xpert was both more expensive and less effective than smear microscopy for that particular clinical outcome.